|
EP2393936A2
|
|
Compositions, kits, and methods for determining plasmin activity
|
|
EP2321336A1
|
|
Method of preparing alpha-1 proteinase inhibitor
|
|
BRPI0819780A2
|
|
Recombinantly modified plasma.
|
|
CA2703393A1
|
|
Method, composition, and article of manufacture for providing alpha-1 antitrypsin
|
|
AU2008206309A1
|
|
Human erythrovirus
|
|
WO2008030825A2
|
|
Apparatus and method for handling and opening a frangible container
|
|
TW200733970A
|
|
Recombinantly modified plasmin
|
|
MXPA06012236A
|
|
Recombinantly modified plasmin.
|
|
US7544500B2
|
|
Process for the production of a reversibly inactive acidified plasmin composition
|
|
US6984492B2
|
|
Methods and compositions for treating herpes infections
|
|
US6969515B2
|
|
Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
|
|
US6964764B2
|
|
Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
|
